• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Prevalence of blood eosinophilia in hospitalized patients with acute exacerbation of COPD.慢性阻塞性肺疾病急性加重期住院患者血嗜酸性粒细胞增多症的患病率。
Respirology. 2016 May;21(4):761-4. doi: 10.1111/resp.12724. Epub 2015 Dec 23.
2
Eosinophil counts in first COPD hospitalizations: a comparison of health service utilization.慢性阻塞性肺疾病首次住院时的嗜酸性粒细胞计数:医疗服务利用情况比较
Int J Chron Obstruct Pulmon Dis. 2018 Oct 1;13:3045-3054. doi: 10.2147/COPD.S170743. eCollection 2018.
3
Eosinophils in COPD Exacerbations Are Associated With Increased Readmissions.COPD 加重期的嗜酸性粒细胞与住院次数增加有关。
Chest. 2017 Feb;151(2):366-373. doi: 10.1016/j.chest.2016.10.003. Epub 2016 Oct 13.
4
The association between eosinophilic exacerbation and eosinophilic levels in stable COPD.稳定期 COPD 中嗜酸性粒细胞恶化与嗜酸性粒细胞水平的关系。
BMC Pulm Med. 2021 Mar 2;21(1):74. doi: 10.1186/s12890-021-01443-4.
5
Blood Eosinophilia and Its Stability in Hospitalized COPD Exacerbations are Associated with Lower Risk of All-Cause Mortality.住院 COPD 加重期血嗜酸性粒细胞增多及其稳定性与全因死亡率降低相关。
Int J Chron Obstruct Pulmon Dis. 2020 May 19;15:1123-1134. doi: 10.2147/COPD.S245056. eCollection 2020.
6
Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD.持续性血嗜酸性粒细胞增多症的患病率:与 COPD 患者结局的关系。
Eur Respir J. 2017 Nov 22;50(5). doi: 10.1183/13993003.01162-2017. Print 2017 Nov.
7
Demographic and Clinical Characteristics of COPD Patients at Different Blood Eosinophil Levels in the UK Clinical Practice Research Datalink.英国临床实践研究数据链中不同血液嗜酸性粒细胞水平的慢性阻塞性肺疾病患者的人口统计学和临床特征
COPD. 2018 Apr;15(2):177-184. doi: 10.1080/15412555.2018.1441275. Epub 2018 Mar 20.
8
Blood Eosinophils and Outcomes in Severe Hospitalized Exacerbations of COPD.血液嗜酸性粒细胞与 COPD 严重住院加重期的结局。
Chest. 2016 Aug;150(2):320-8. doi: 10.1016/j.chest.2016.01.026. Epub 2016 Feb 3.
9
[Prevalence of blood eosinophilia in adults with COPD according to the cut-off point].[根据临界点划分慢性阻塞性肺疾病(COPD)成年患者血液嗜酸性粒细胞增多症的患病率]
Rev Alerg Mex. 2021 Jul-Sep;68(3):152-159. doi: 10.29262/ram.v67i3.893.
10
Blood Eosinophil Count and Hospital Readmission in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.血液嗜酸性粒细胞计数与慢性阻塞性肺疾病急性加重患者的住院再入院。
Int J Chron Obstruct Pulmon Dis. 2020 Oct 23;15:2629-2641. doi: 10.2147/COPD.S251115. eCollection 2020.

引用本文的文献

1
Implication of Admission Eosinophil Count and Prognosis of Coronavirus Disease 2019 (COVID-19) in Elderly Patients With COPD: A Territory-Wide Cohort Study.入院嗜酸性粒细胞计数与慢性阻塞性肺疾病(COPD)老年患者2019冠状病毒病(COVID-19)预后的关系:一项全地区队列研究。
Clin Respir J. 2025 Apr;19(4):e70070. doi: 10.1111/crj.70070.
2
High blood eosinophils predict the risk of COPD exacerbation: A systematic review and meta-analysis.高血嗜酸性粒细胞预测 COPD 加重风险:系统评价和荟萃分析。
PLoS One. 2024 Oct 3;19(10):e0302318. doi: 10.1371/journal.pone.0302318. eCollection 2024.
3
Meta-analysis of peripheral blood eosinophils in clinical testing of chronic obstructive pulmonary disease patients.慢性阻塞性肺疾病患者临床检测中外周血嗜酸性粒细胞的Meta分析。
Postepy Dermatol Alergol. 2024 Apr;41(2):155-163. doi: 10.5114/ada.2024.139124. Epub 2024 Apr 24.
4
Glucocorticoid Use in Patients Hospitalized with Chronic Obstructive Pulmonary Disease Exacerbations.慢性阻塞性肺疾病加重住院患者的糖皮质激素使用。
Int J Chron Obstruct Pulmon Dis. 2024 Feb 12;19:431-438. doi: 10.2147/COPD.S436326. eCollection 2024.
5
Predictors of Readmission, for Patients with Chronic Obstructive Pulmonary Disease (COPD) - A Systematic Review.慢性阻塞性肺疾病(COPD)患者再入院的预测因素——一项系统综述
Int J Chron Obstruct Pulmon Dis. 2023 Nov 18;18:2581-2617. doi: 10.2147/COPD.S418295. eCollection 2023.
6
Using inflammatory index to distinguish asthma, asthma-COPD overlap and COPD: A retrospective observational study.利用炎症指标区分哮喘、哮喘-慢性阻塞性肺疾病重叠综合征和慢性阻塞性肺疾病:一项回顾性观察研究。
Front Med (Lausanne). 2022 Nov 17;9:1045503. doi: 10.3389/fmed.2022.1045503. eCollection 2022.
7
2021 Guideline for the Management of COPD Exacerbations: Emergency Medicine Association of Turkey (EMAT) / Turkish Thoracic Society (TTS) Clinical Practice Guideline Task Force.《2021年慢性阻塞性肺疾病急性加重管理指南:土耳其急诊医学协会(EMAT)/土耳其胸科学会(TTS)临床实践指南工作组》
Turk J Emerg Med. 2021 Oct 29;21(4):137-176. doi: 10.4103/2452-2473.329630. eCollection 2021 Oct-Dec.
8
Long-term oxygen treatment need is less frequent in eosinophilic COPD patients.嗜酸性粒细胞性 COPD 患者的长期氧疗需求较少。
Clin Respir J. 2022 Jan;16(1):49-56. doi: 10.1111/crj.13451. Epub 2021 Oct 26.
9
Blood eosinophil count-guided corticosteroid therapy and as a prognostic biomarker of exacerbations of chronic obstructive pulmonary disease: a systematic review and meta-analysis.血液嗜酸性粒细胞计数指导的皮质类固醇治疗作为慢性阻塞性肺疾病急性加重的预后生物标志物:一项系统评价和荟萃分析。
Ther Adv Chronic Dis. 2021 Jul 7;12:20406223211028768. doi: 10.1177/20406223211028768. eCollection 2021.
10
The association between eosinophilic exacerbation and eosinophilic levels in stable COPD.稳定期 COPD 中嗜酸性粒细胞恶化与嗜酸性粒细胞水平的关系。
BMC Pulm Med. 2021 Mar 2;21(1):74. doi: 10.1186/s12890-021-01443-4.

本文引用的文献

1
Prevalence of eosinophilia in hospitalized patients with asthma exacerbation.哮喘急性加重住院患者中嗜酸性粒细胞增多症的患病率。
Respir Med. 2015 Sep;109(9):1230-2. doi: 10.1016/j.rmed.2015.07.011. Epub 2015 Jul 17.
2
Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management.慢性阻塞性肺疾病药物治疗的靶向治疗现状:向个性化管理迈进
Lancet. 2015 May 2;385(9979):1789-1798. doi: 10.1016/S0140-6736(15)60693-6.
3
Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials.血液嗜酸性粒细胞计数、加重情况以及慢性阻塞性肺疾病患者添加吸入氟替卡松维兰特罗后的反应:两项平行随机对照试验数据的二次分析。
Lancet Respir Med. 2015 Jun;3(6):435-42. doi: 10.1016/S2213-2600(15)00106-X. Epub 2015 Apr 12.
4
Eosinophilic inflammation in COPD: prevalence and clinical characteristics.慢性阻塞性肺疾病中的嗜酸性粒细胞炎症:患病率及临床特征
Eur Respir J. 2014 Dec;44(6):1697-700. doi: 10.1183/09031936.00162414. Epub 2014 Oct 16.
5
Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study.贝那鲁肽治疗慢性阻塞性肺疾病和痰嗜酸性粒细胞增多症:一项随机、双盲、安慰剂对照、2a 期研究。
Lancet Respir Med. 2014 Nov;2(11):891-901. doi: 10.1016/S2213-2600(14)70187-0. Epub 2014 Sep 7.
6
Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis.血液嗜酸性粒细胞指导的泼尼松龙治疗慢性阻塞性肺疾病急性加重:进一步分析
Eur Respir J. 2014 Sep;44(3):789-91. doi: 10.1183/09031936.00062614. Epub 2014 Jun 12.
7
Frequent utilization of the emergency department for acute exacerbation of chronic obstructive pulmonary disease.经常利用急诊部门治疗慢性阻塞性肺疾病的急性加重。
Respir Res. 2014 Apr 10;15(1):40. doi: 10.1186/1465-9921-15-40.
8
Unsupervised phenotyping of Severe Asthma Research Program participants using expanded lung data.利用扩展的肺部数据对重度哮喘研究项目参与者进行无监督表型分析。
J Allergy Clin Immunol. 2014 May;133(5):1280-8. doi: 10.1016/j.jaci.2013.11.042. Epub 2014 Feb 28.
9
The clinical and economic burden of chronic obstructive pulmonary disease in the USA.美国慢性阻塞性肺疾病的临床和经济负担。
Clinicoecon Outcomes Res. 2013 Jun 17;5:235-45. doi: 10.2147/CEOR.S34321. Print 2013.
10
COPD surveillance--United States, 1999-2011.慢性阻塞性肺疾病监测——美国,1999-2011 年。
Chest. 2013 Jul;144(1):284-305. doi: 10.1378/chest.13-0809.

慢性阻塞性肺疾病急性加重期住院患者血嗜酸性粒细胞增多症的患病率。

Prevalence of blood eosinophilia in hospitalized patients with acute exacerbation of COPD.

作者信息

Hasegawa Kohei, Camargo Carlos A

机构信息

Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

出版信息

Respirology. 2016 May;21(4):761-4. doi: 10.1111/resp.12724. Epub 2015 Dec 23.

DOI:10.1111/resp.12724
PMID:26699685
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7712630/
Abstract

In this cohort of 3084 patients hospitalized for acute exacerbation of COPD (AECOPD), we found that 17% had blood eosinophilia (≥300 cells/μL); the use of an alternative cut-off level (≥2%) demonstrated that 40% had elevated eosinophil count. Patients with eosinophilia had higher frequency of readmission for AECOPD during 1-year follow-up period. This is the first study to investigate the prevalence of eosinophilia among inpatients with AECOPD--the population with the highest morbidity and health-care utilization.

摘要

在这组3084例因慢性阻塞性肺疾病急性加重(AECOPD)住院的患者中,我们发现17%的患者存在血嗜酸性粒细胞增多(≥300个细胞/μL);采用另一个临界值水平(≥2%)显示,40%的患者嗜酸性粒细胞计数升高。嗜酸性粒细胞增多的患者在1年随访期内因AECOPD再次入院的频率更高。这是第一项调查AECOPD住院患者(发病率和医疗保健利用率最高的人群)中嗜酸性粒细胞增多患病率的研究。